These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 30652497)
1. Inhibition of GGPPS1 attenuated LPS-induced acute lung injury and was associated with NLRP3 inflammasome suppression. Xu WJ; Wang XX; Jin JJ; Zou Q; Wu L; Lv TF; Wan B; Zhan P; Zhu SH; Liu HB; Zhao NW; Li CJ; Song Y Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L567-L577. PubMed ID: 30652497 [TBL] [Abstract][Full Text] [Related]
2. Geranylgeranyl diphosphate synthase 1 knockdown suppresses NLRP3 inflammasome activity via promoting autophagy in sepsis-induced acute lung injury. Li D; Li C; Wang T; Zhang C; Zhu Z; Zhang G; Fang B Int Immunopharmacol; 2021 Nov; 100():108106. PubMed ID: 34530204 [TBL] [Abstract][Full Text] [Related]
3. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation. Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555 [TBL] [Abstract][Full Text] [Related]
5. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation. Yang HH; Duan JX; Liu SK; Xiong JB; Guan XX; Zhong WJ; Sun CC; Zhang CY; Luo XQ; Zhang YF; Chen P; Hammock BD; Hwang SH; Jiang JX; Zhou Y; Guan CX Theranostics; 2020; 10(11):4749-4761. PubMed ID: 32308747 [No Abstract] [Full Text] [Related]
6. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation. Meng Q; Wang X; Guo D; Shi C; Gu R; Ma J; Nieman G; Kollisch-Singule M; Luo J; Cooney RN Shock; 2022 May; 57(5):749-758. PubMed ID: 35583915 [TBL] [Abstract][Full Text] [Related]
7. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation. Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368 [TBL] [Abstract][Full Text] [Related]
8. Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway. Chen H; Ding Y; Chen W; Feng Y; Shi G Drug Des Devel Ther; 2019; 13():1545-1554. PubMed ID: 31123394 [No Abstract] [Full Text] [Related]
9. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury. Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237 [TBL] [Abstract][Full Text] [Related]
10. Catechin regulates miR-182/GGPPS1 signaling pathway and inhibits LPS-induced acute lung injury in mice. Zhao Y; Zheng H; Yang S; Zhang X; Dong W; Shi Y; Li Y; Feng J Immunopharmacol Immunotoxicol; 2022 Feb; 44(1):58-66. PubMed ID: 34845949 [TBL] [Abstract][Full Text] [Related]
11. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation. Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759 [TBL] [Abstract][Full Text] [Related]
12. Sestrin 2 protects against LPS-induced acute lung injury by inducing mitophagy in alveolar macrophages. Wu D; Zhang H; Wu Q; Li F; Wang Y; Liu S; Wang J Life Sci; 2021 Feb; 267():118941. PubMed ID: 33359748 [TBL] [Abstract][Full Text] [Related]
14. USP9X promotes lipopolysaccharide-stimulated acute lung injury by deubiquitination of NLRP3. Xiang Y; Li X; Cai M; Cai D Cell Biol Int; 2023 Feb; 47(2):394-405. PubMed ID: 36525374 [TBL] [Abstract][Full Text] [Related]
15. Sevoflurane suppresses NLRP3 inflammasome-mediated pyroptotic cell death to attenuate lipopolysaccharide-induced acute lung injury through inducing GSK-3β phosphorylation and activation. Zheng F; Wu X; Zhang J; Fu Z Int Immunopharmacol; 2022 Aug; 109():108800. PubMed ID: 35550264 [TBL] [Abstract][Full Text] [Related]
16. Autophagy alleviates mitochondrial DAMP-induced acute lung injury by inhibiting NLRP3 inflammasome. Peng W; Peng F; Lou Y; Li Y; Zhao N; Shao Q; Chen J; Qian K; Zeng Z; Zhan Y; Jiang R; Liu F Life Sci; 2021 Jan; 265():118833. PubMed ID: 33275990 [TBL] [Abstract][Full Text] [Related]
17. Glycyrrhetinic acid alleviates acute lung injury by PI3K/AKT suppressing macrophagic Nlrp3 inflammasome activation. Wang K; Zhang Y; Cao Y; Shi Z; Lin Y; Chen Y; Zhao H; Liu X Biochem Biophys Res Commun; 2020 Nov; 532(4):555-562. PubMed ID: 32900490 [TBL] [Abstract][Full Text] [Related]
18. Emodin Attenuates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis Signaling Pathway In vitro and In vivo. Liu Y; Shang L; Zhou J; Pan G; Zhou F; Yang S Inflammation; 2022 Apr; 45(2):753-767. PubMed ID: 34787801 [TBL] [Abstract][Full Text] [Related]
19. CaMK4 Promotes Acute Lung Injury Through NLRP3 Inflammasome Activation in Type II Alveolar Epithelial Cell. Zhang T; Li M; Zhao S; Zhou M; Liao H; Wu H; Mo X; Wang H; Guo C; Zhang H; Yang N; Huang Y Front Immunol; 2022; 13():890710. PubMed ID: 35734175 [TBL] [Abstract][Full Text] [Related]
20. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3. Lin Y; Yang Y Pathol Res Pract; 2019 Apr; 215(4):683-688. PubMed ID: 30600184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]